Coronary disease & ACSCohort study

Microvascular resistance reserve: impact on health status and myocardial perfusion after revascularization in chronic coronary syndrome

Eur Heart JPublished

  • Prospective cohort study

Authors' conclusion

In patients with moderate coronary stenoses, MRR seems to predict the symptomatic and perfusion benefit of revascularization.

Study context

Population
Consecutive patients with stable chest pain and moderate (30%-90% diameter) stenoses on invasive coronary angiography
Participants
222 patients
Exposure
Microvascular resistance reserve (MRR) and revascularization status
Outcome
Freedom from angina
Follow-up
follow-up

Main finding

As reported in the abstract

Odds ratio

0.860

95% CI 0.740–0.987

MRR
OR 0.860 (95% CI 0.740–0.987)
Freedom from angina
38/173

Observational data: associations, not effects.

Secondary outcomes

Seattle Angina Questionnaire (SAQ) angina frequency score

Comparisonmean difference (CI)
Normal MRR, no revascularization8.5 (3.07–13.11)
Abnormal MRR, revascularization13.5 (2.82–23.16)

SAQ physical limitation score

Comparisonmean difference (CI)
Normal MRR, no revascularization9.7 (4.79–11.93)
Abnormal MRR, revascularization8.7 (0.53–13.88)

SAQ summary score

Comparisonmean difference (CI)
Normal MRR, no revascularization9.3 (5.18–12.50)
Abnormal MRR, revascularization10.8 (2.51–17.28)

Myocardial perfusion (PET)

Only patients with abnormal MRR who underwent revascularization had improved myocardial perfusion

Original publication

Microvascular resistance reserve: impact on health status and myocardial perfusion after revascularization in chronic coronary syndrome. Eur Heart J. Published 1 September 2024. doi:10.1093/eurheartj/ehae604

Summarised from the published abstract; every number is checked against it